37 results on '"Le Pavec, Jérôme"'
Search Results
2. Thirty years of surgical management of pediatric pulmonary hypertension: Mid-term outcomes following reverse Potts shunt and transplantation
3. 2022 Update of indications and contraindications for lung transplantation in France
4. Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease
5. Evaluación multiparamétrica de la función ventricular derecha en la hipertensión arterial pulmonar asociada a cardiopatías congénitas
6. Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study
7. Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
8. Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G
9. Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort
10. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
11. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements
12. Transplantation for pulmonary arterial hypertension with congenital heart disease: Impact on outcomes of the current therapeutic approach including a high-priority allocation program
13. Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study
14. Transplantation for Pulmonary Arterial Hypertension with Congenital Heart Disease: Impact of current therapeutic approach including a high-priority allocation programme on outcomes
15. Lung and heart-lung transplantation for children with PAH: Dramatic benefits from the implementation of a high-priority allocation program in France
16. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study
17. Can radiation-recall predict long lasting response to immune checkpoint inhibitors?
18. Pneumocystis pneumonia after lung transplantation: A retrospective multicenter study
19. Anakinra for severe forms of COVID-19: a cohort study
20. Lung transplantation for idiopathic pulmonary fibrosis
21. The 2016–2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study
22. Combined lung transplantation and percutaneous septal defect closure for end-stage atrial septal defect associated pulmonary arterial hypertension
23. The 2016-2019 ImmunoTOX Assessment Board Report: Results from a Descriptive Real-Life Study of a Collaborative Management of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors
24. Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study
25. Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
26. Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension
27. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
28. Prescription difficile d’un traitement anticoagulant au cours du syndrome de Hughes-Stovin sévère
29. De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome
30. Life-threatening Hughes-Stovin syndrome: The Yin and Yang of anticoagulation therapy
31. Consortium de détection et prise en charge des atteintes pulmonaires induites par la bléomycine
32. Severe hematologic complications after lung transplantation in patients with telomerase complex mutations
33. Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group
34. Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension
35. Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease
36. Hypertension artérielle pulmonaire et sclérodermie systémique : les pièges
37. Centres de référence “maladies rares respiratoires”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.